Nivalis therapeutics inc articles
-
Lexeo Therapeutics, Inc.’s Lock-Up Period Set To End on May 1st (NASDAQ:LXEO)
Lexeo Therapeutics’ (NASDAQ:LXEO – Get Free Report) lock-up period is set to expire on Wednesday, May 1st. Lexeo Therapeutics had issued 9,090,910 shares in its public offering on November 3rd. The total size of the offering was $100,000,010 based on an initial share price of $11.00. After the end of the company’s lock-up period, major […]
-
MCF Advisors LLC Purchases 204,170 Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX)
MCF Advisors LLC boosted its position in Poseida Therapeutics, Inc. (NASDAQ:PSTX – Free Report) by 476.4% in the fourth quarter, Holdings Channel.com reports. The firm owned 247,024 shares of the company’s stock after buying an additional 204,170 shares during the quarter. MCF Advisors LLC’s holdings in Poseida Therapeutics were worth $830,000 as of its most […]
-
Alphabet Inc. (NASDAQ:GOOG) Shares Acquired by Evolution Advisers Inc.
Evolution Advisers Inc. boosted its position in shares of Alphabet Inc. (NASDAQ:GOOG – Free Report) by 200.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 600 shares of the information services provider’s stock after buying an additional 400 shares during the […]